LONDON, March 30, 2017 /PRNewswire/ -- Trends, opportunities and forecast in this market to 2022 by procedure, which includes repair (annuloplasty, valvuloplasty, transcatheter mitral valve repair, and other repairs) and replacement (surgical valves, mechanical heart valves, tissue heart valves, and transcatheter aortic valves), position (aorta, mitral, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World).

New research from a veteran-focused healthcare provider shows that U.S. veterans suffering from heart disease and depression are more likely to struggle receiving regular healthcare access and paying bills compared to those that don’t face mental health challenges. 

Espero Pharmaceuticals and Armetheon announced on March 30 that they planned on merging to form a company focused on developing cardiovascular medications. Both companies are privately held.

During a ceremony on March 30, Massachusetts Governor Charlie Baker and others celebrated the grand opening of Abiomed’s expanded headquarters in Danvers, Massachusetts.

Miguel Gomez, III, MD, a former heart surgeon at Memorial Hermann hospital in Houston, won $6.4 million in a legal battle with the health system after alleging that it wrongly targeted him over his ethics, reports KHOU.com

A new study conducted by the Canadian Pharmacists Association found that comprehensive, long-term pharmacist care for Canadians suffering from hypertension could improve outcomes and save more than $15.7 billion.

Cardiologists and researchers fear that President Donald Trump’s 20 percent cut to the National Institutes of Health (NIH) budget could limit the number of trials and life-saving medications, Reuters reports.

Between 1992 and 2014, the rate of paid malpractice claims decreased 13.5 percent in cardiology and declined 55.7 percent in all medical specialties, according to a database analysis.